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Summary 
A rapid induction of adhesion to immobilized intercellular adhesion molecule (ICAM)-I occurs 
when cytotoxic T  lymphocytes (CTL)  are  stimulated with  either  soluble anti-T  cell receptor 
(TCR) monoclonal antibodies (mAb) or with immobilized alloantigen, and this binding is blocked 
by the addition  of anti-lymphocyte function-associated  (LFA)-I mAbs.  Requirements  for ac- 
tivating LFA-1 adhesion to ICAM-1 are similar to those found for induction of binding to im- 
mobilized fibronectin (FN), but distinct from those for activating CD8-mediated  adhesion to 
class I major histocompatibility complex. A distinct  role for LFA-1 in co-signaling for TCR- 
dependent degranulation could not be demonstrated. In contrast, both CD8 and the FN-binding 
integrin provide costimulatory signals for this response. Thus, if co-signaling via LFA-1 occurs, 
it clearly differs from that provided by CD8 or the FN-binding integrin.  On the basis of anti- 
body blocking effects,  alloantigen-dependent  activation of adhesion to ICAM-1 involves both 
the TCR and CD8.  These results support a view of CTL activation as a cascade of adhesion 
and  signaling  events, with  different coreceptors making  distinct  contributions. 
2•ctivation 
of CTLs involves not only the recognition of 
antigen via the TCR but also interaction of accessory 
receptors with their specific ligands. For several of these ac- 
cessory receptors, engagement of the TCR results in increased 
binding  to  ligand.  Thus,  although  the  interaction  of the 
receptor-ligand pairs is antigen-independent,  the activation 
steps that  lead to adhesion are dependent  on occupancy of 
the TCR. The receptor-ligand systems shown to be activated 
via the TCR include CD8/class I MHC (1), LFA-1/intercel- 
lular  adhesion  molecule  (ICAM-1)  (2),  very late  antigen 
(VLA)-4/fibronectin (FN), VLA-5/FN, VLA-6/laminin (3, 
4), and CD2/LFA-3 (5). Evidence is accumulating to indi- 
cate that, in addition to mediating adhesion, accessory receptors 
can  generate  costimulatory  signals.  LFA-1  and  the  VLA 
receptors have been shown to have costimulatory activity for 
antibody-activated  proliferation  of  CD4 +  T  cells  (6-8). 
Similarly, our previous studies of CDS/class I and VLA/FN 
interactions  have demonstrated adhesion and costimulatory 
roles for these receptors in generation of CTL functional re- 
sponse (9). 1 Furthermore,  these studies have suggested that 
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these two receptor ligand  systems are involved in a cascade 
of signaling  events, rather  than  sharing a common mecha- 
nism and redundant roles in the generation of CTL response. 
Recent studies suggest that other T cell accessory receptors 
may also contribute costimulatory signals capable of influ- 
encing the CTL response. Studies of CD4 + T  cells suggest 
that the high affinity adhesion of LFA-1 to ICAM-1 can de- 
liver an activation signal to T cells in addition to mediating 
adhesion (6, 10). Here, we have examined the potential con- 
tributions of adhesion of LFA-1 to ICAM-1 to the functional 
response of CTL to soluble mAb and to purified antigen. 
The results described in the present report strongly suggest 
that the contribution of the LFA-1/ICAM-1 interaction to 
the adhesion/signaling cascade is distinct from that of either 
VLA/FN  or CD8/class  I. 
Materials and Methods 
Cloned CTL Lines.  Clones 11 and 35, of (B10.BR. x B10.D2)F1 
origin, are specific for K b alloantigen and have been described pre- 
viously (11). Clone OE4 is of C57BL/6 origin and is specific for 
H-2  d alloantigen (12). Clones were maintained by weekly restimu- 
lation with irradiated (3,000 R) spleen cells (C57BL/6 or DBA/2) 
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plemented with 20 mM Hepes,  2 mM L-glutamine,  5  x  10 -s M 
2-ME, penicillin-streptomycin (100 U/ml),  1 mM sodium pyru- 
vate, 0.1 mM nonessential amino adds, 2.5% FCS, and 1.0% CMF- 
11 nutrient supplement (J. Brooks Laboratories,  San Diego, CA). 
Antibodies.  mAb F23.1, a mouse Ab specific for V38 (13) was 
purified from ascites fluid by affinity chromatography on Protein 
A-Sepharose.  Goat  anti-mouse  IgG  (H  and  L  chains)  (Fisher 
Scientific,  Pittsburgh,  PA) was used in some experiments to fur- 
ther cross-link the F23.1 mAb. The anti-LFA-1 mAb FD441.8 was 
purified from hybridoma culture supernatant by ammonium sul- 
fate precipitation. The anti-ICAM-1 mAb (10) was used as a hy- 
bridoma culture supernatant. The mAb anti-Lyt-2 53-6.7 (14) was 
purified by ammonium sulfate fractionation followed by DEAE chro- 
matography. M1/42, a rat anti-mouse class I mAb (15), was purified 
from culture supernatant by ammonium sulfate precipitation  fol- 
lowed by DEAE chromatography and used to detect immobilized 
K b alloantigen by ELISA. 
Ligands.  A  secreted  form  of the  murine  ICAM-1  protein 
(ICAM-ls) was generated as described previously from a truncated 
ICAM-1 cDNA coding for the first four extracellular domains and 
a portion of the fifth domain of the ICAM-1 protein, but lacking 
the putative transmembrane and cytoplasmic domains (10). Purified 
murine plasma FN was purchased from Telios Pharmaceuticals,  Inc. 
(San Diego, CA). ICAM-ls and FN were diluted in PBS for use 
in functional assays. H-2 K b was purified  from TX-100 lysates of 
EL4 (KUD  b) tumor cells by mAb affinity chromatography as pre- 
viously described  (15). H-2K  k was purified  from TX-100 lysates 
of RDM4 (KkD  ~) cells (16). H-2 preparations  were quantitated  by 
protein determination and by ELISA relative to standard prepara- 
tions. Purity of the Ag preparations was determined by SDS-PAGE. 
Protein Immobilization.  Purified  H-2 antigens  were stored  at 
-20~  in 10 mM Tris buffer containing 0.5% deoxycholate and 
NaC1 at concentrations of 20-160 mM. For use, class I protein was 
diluted directly into PBS (pH 7.4) to concentrations ranging from 
0.1 to 2 #g/ml. 0.1 ml aliquot/well of diluted  H-2 was then in- 
cubated for 1.5 h at  25~  in flat bottom wells of Microtiter III 
flexible assay plates (Falcon Labware, Oxnard, CA). Binding of H-2 
increased  linearly with input up to a level of 0.15-0.3 #g/ml,  as 
determined by ELISA (17). After a 1.5-h incubation, the wells were 
washed with 0.1%  BSA in PBS to remove unbound Ag and to 
block unoccupied sites on the plastic. 
ICAM-ls and FN were diluted in PBS and immobilized by addi- 
tion to microtiter plate wells and incubation at room temperature 
for 1.5 h.  The wells  were then washed and blocked with 0.1% 
BSA as described  above. Co-immobilization of ICAM-ls and H-2 
was accomplished by adding ICAM-ls to the wells first.  After a 
1.5-h incubation, the wells were washed with PBS to remove un- 
bound ICAM-ls, and H-2 was immobilized as described  above. 
Assay ofCTL Degranulation.  The release of serine esterase ac- 
tivity in response  to proteins immobilized in microtiter wells was 
determined by the addition of 1  x  105 CTL/well in 0.1  ml of 
RPMI supplemented with 2% FCS and 15 mM Hepes. Plates were 
centrifuged at  1,000 for 1 min and incubated at 37~  for times 
ranging from 30 rain-5 h. After incubation, 0.02-ml aliquots  of 
cell free supernatant were removed and serine esterase activity de- 
termined as previously described (11). All experiments included tripli- 
cate determinations  and standard deviations  are shown. 
Assay of CTL Binding.  CTLs were labeled by overnight incu- 
bation in complete medium at 37~  with 1 #Ci [3H]thymidine 
per 2-5  x  l0  s cells. Cells were washed and resuspended at 106/ml 
in RPMI with 2% FCS and 15 mM Hepes. Binding was initiated 
by adding l0  s ceils per well in 0.1  ml and centrifuging the mi- 
crotiter plates  at 1,000 rpm for 1 min. After a 2-h incubation at 
37~  binding was determined as described previously (9). In some 
experiments,  SE release and binding were determined for the same 
cells. To accomplish  this, 0.02-ml aliquots  of supernatant were re- 
moved from the wells for esterase activity determination before 
proceeding with the binding assay. In blocking studies,  purified 
mAb were added  to CTL before  initiation of the binding assay. 
Assay of Phosphoinositide Hydrolysis.  For  determination  of 
[3H]inositol phosphate release, CTL clones were labeled overnight 
with [3H]myo-inositol  in inositol-deficient  Eagle's basal medium 
supplemented with 10% (vol/vol) dialyzed FCS, containing 10-15 
/zCi/ml [3H]myo-inositol (S.A. 60-100 Ci/mmol, Amersham).  La- 
beled CTL were incubated with stimuli in RPMI 1690 containing 
10 mM Hepes,  10 mM LiC1, and 0.1%  (wt/vol) BSA. [3H]Ino- 
sitol phosphates were extracted  after 120 min by addition of meth- 
anol/chloroform/HC1 and quantitated by Dowex (Dow Chemical 
Co., Midland,  MI) (HCOO-) ion-exchange chromatography as 
previously described  (9). 
Results  and  Discussion 
Fluid-Phase  Anti-TCR mAb Triggers  Adhesion of CTL to Im- 
mobilized ICAM-ls.  Murine ICAM-ls can be directly im- 
mobilized on plastic by dilution  in PBS and incubation in 
microtiter wells. Under the conditions used, the amount of 
ICAM-ls immobilized is maximal upon addition of 0.3-0.5 
#g/well (Fig. 1 A). Cloned routine CTL bound to immobi- 
lized  ICAM-ls  upon  stimulation  with  soluble  anti-TCR 
mAbs, F23.1, as seen in Fig. 1 B. Unstimulated CTL showed 
a low but significant basal level of binding to ICAM-ls, which 
was significantly increased upon the addition of F23.1 anti- 
TCR mAbs. The addition of a second cross-linking Ab fur- 
ther  increased  adhesion  to  levels  more  than  double  those 
reached with  F23.1  alone.  The  addition  of an  anti-LFA-1 
blocking mAb (FD441.8) inhibited binding of CTL to im- 
mobilized ICAM-ls, confirming that the activated adhesion 
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Figure  1.  Soluble  anti-TCR Ab triggers CTL binding to immobilized 
ICAM-ls. The indicated concentrations of ICAM-ls were immobilized 
in microtiter wells and the wells blocked  with 0.1% BSA. (A) ELISA  assay 
of immobilized ICAM-ls using BE29G1 anti-ICAM-1 mAb (1:13,000) 
dilution followed  by HRP-linked goat anti-rat Ig as second  Ab. (B) CTL 
clone 11 was either not stimulated (<~-), stimulated with F23.1 mAb 
(-C]--), or with F23.1 and goat anti-mouse IgG (anti-IgG) (--O-). After 
a 2.5-h incubation at 37~  percent specific binding was determined as 
described in Materials and Methods. For Ab blocking, anti-LFA-1 mAb 
FD441.8 was added to CTL at a concentration of 75 #g/ml before addi- 
tion of  the cells to the ICAM-1 bearing wells. FD441.8  was added to CTL 
stimulated with F23.1 ([13) or F23.1 and second Ab (G). 
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a 2-h incubation and 0.2-0.3 mg/well immobilized ICAM- 
ls (data not  shown).  The Ab-triggered binding of CTL to 
immobilized ICAM-ls can be compared with previous studies 
with  immobilized  class  I  and  FN.  The  augmentation  of 
binding observed with addition of cross-linking Abs together 
with anti-TCR  was also observed with  immobilized FN 1. 
In contrast,  activated adhesion to irrelevant class I MHC via 
CD8 was not augmented by the addition of a second cross- 
linking Ab,  suggesting  that the activation steps leading  to 
triggered binding of CD8 to class I differ from those involved 
in  triggered  binding  to  ICAM-ls  and  FN. 
Co-immobilized Suboptimal Levels of  Alloantigen Trigger  Adhe- 
sion to Immobilized ICAM-Is.  To examine Ag-activated adhe- 
sion to ICAM-ls,  a  suboptimal level of H-2K  b alloantigen 
was immobilized together with a range of concentrations of 
ICAM-ls. The concentration of K b used (0.02/zg/well)  was 
insufficient to mediate CTL adhesion when immobilized alone. 
However,  the presence of K b resulted in induction  of adhe- 
sion to co-immobilized ICAM-ls (Fig.  2), and the addition 
of blocking  anti-LFA-1  mAb resulted in significant inhibi- 
tion  of adhesion.  In addition  to occupying  the  TCtL,  im- 
mobilized K b is also a ligand for CDS.  While  the concen- 
tration of K b immobilized is too low to support detectable 
CTL adhesion via CD8, it seemed possible that TCR-activated 
binding  of CD8  to  K b could  contribute  to  activation  of 
binding  to  ICAM-ls.  To assess this  possibility,  the  ability 
of an anti-CD8 mAb to block binding was determined. The 
addition  of anti-CD8  Abs substantially inhibited  adhesion, 
suggesting that both TCR and CD8 interactions with class 
I MHC are involved in activating LFA-1 dependent adhesion 
to  ICAM-ls. 
Binding to Immobilized ICAM-ls, FN, and Nonantigenic Class 
I MHC Have Different Co-signaling Effects.  Stimulation with 
soluble anti-TCR mAbs alone is sufficient to trigger adhe- 
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Figure  2.  Suboptimal levels of alloantigen stimulate adhesion to im- 
mobilized ICAM-ls.  CTL clone 11 was incubated in wells coated with 
the indicated concentrations of ICAM-ls alone or in wells coated with 
0.02/zg/well of K  b together with ICAM-ls. Where indicated, anti-LFA-1 
mAb at 75/zg/ml or anti-CD8 mAb at 10/.tg/ml were present. Percent 
specific binding was determined as described. --0-control; --(/]- +Kb; 
-￿9  +anti-LFA-1; -'CF-  +Kb+anti-LFA-1;  -A--  +anti-CD8;  --/k- 
+ K  b + anti-CDS. 
sion of CTL to immobilized class I MHC  (Kk),  ICAM-ls, 
or FN  (Fig.  3  A).  The  addition  of a  second  cross-linking 
Ab resulted in increased adhesion to ICAM-ls and FN, but 
had  no  effect on  the  level of binding  to  K k.  Thus,  as de- 
scribed above, activated adhesion to class I differed from adhe- 
sion to FN or to ICAM-1, which appear to have similar prop- 
erties.  In contrast,  all three ligands were found  to differ in 
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Figure  3.  ICAM-ls, FN, and class I MHC have different co-signaling 
effects. CTL clone 11 was stimulated with the indicated Abs and added 
to wells coated with 0.5 #g/well of FN, 0.2 ~g/well  ICAM-ls,  or 0.2 
gg/well class I MHC (Kk). After a 5-h incubation, (A) CTL binding and 
(B) serine esterase release were determined as described. (C) Total [3H]ino- 
sitol phosphates were determined in 10S/well [3H]inositol-labeled clone 
11 after a 120-min incubation in the presence of 10 mM LiC1. Results 
are expressed  as mean and range of duplicate samples. ￿9  No Ab; [] +F23.1; 
[]  +F23.1+anti-Ig. 
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tion (Fig.  3 B). When CTL were activated with anti-TCR 
alone, adhesion to class I MHC was sufficient to stimulate 
degranulation,  and the level of serine esterase  released was 
somewhat decreased upon the addition of a cross-linking Ab 
(Fig.  3 B). In contrast,  anti-TCR activated CTL incubated 
with immobilized FN were unable to initiate  a degranula- 
tory response unless  the  second cross-linking  Ab was also 
present (Fig.  3 B), as previously described.  In further con- 
trast, activated adhesion of CTL to ICAM-ls in the presence 
of anti-TCR  alone or with the combination of anti-TCP, s 
and cross-linking Abs did not result in the initiation of de- 
granulation, despite the fact that adhesion was clearly occur- 
ring  under  these conditions.  Additional  experiments  have 
demonstrated that co-signaling is readily detected using 0.1 
#g/well FN, while no co-signaling  is found using up to 1 
/zg/well ICAM-ls (i.e., well above saturating levels, see Fig. 
1 A). Essentially the same results have been obtained in ex- 
periments using native ICAM-1 purified by affinity chroma- 
tography after detergent solubilization (data not shown). Simi- 
larly, a lack of costimulation with ICAM-ls was demonstrated 
with two other allospecific  CTL clones, OE4 and 35, both 
of which undergo TCP,-activated adhesion to ICAM-ls. Thus, 
although the requirement  for activation of adhesion to FN 
and ICAM-1 appears to be the same, the requirements  for 
costimulation  as a result  of binding  clearly are not. 
A recent study of activation of phosphoinositide (PI) hy- 
drolysis in  CTL under  the conditions  described above has 
suggested a possible explanation  for the differential effects 
of class I and FN on costimulation.  As reported, activation 
of murine CTL with fluid phase anti-TCR alone was unable 
to initiate detectable PI hydrolysis (9). Hydrolysis did occur 
if CTL subsequently underwent CD8-mediated adhesion to 
class I MHC, but not VLA-mediated adhesion to FN. Ac- 
tivating CTL with anti-TCR and cross-linking the TCR by 
adding a second Ab resulted in a low but detectable level of 
PI hydrolysis. If the CTL were subsequently allowed to ad- 
here to FN,  a dramatic  increase in PI hydrolysis occurred, 
demonstrating  that while FN was unable to initiate PI hy- 
drolysis, it was capable of amplifying it once it had been ini- 
tiated.  Here, we have determined  the effect of adhesion  to 
immobilized ICAM-ls on PI hydrolysis in Ab-activated CTL. 
For comparison,  CTL were also allowed to adhere to im- 
mobilized FN. CTL were stimulated with either F23.1 alone 
or with F23.1 together with cross-linking Ab and incubated 
in wells coated with BSA, 0.125 #g/well ICAM-ls, or 0.25 
#g/well FN. After a 120-min incubation, PI hydrolysis was 
determined. As expected, binding to FN dramatically  amplified 
PI hydrolysis in the presence of F23.1 and cross-linking anti- 
body (Fig.  3 C).  In contrast,  binding  to ICAM-ls had no 
effect on PI hydrolysis, consistent with the lack of degranu- 
lation under these conditions. While these results do not rule 
out a potential  co-signaling  role,  they clearly demonstrate 
that LFA-1 does not make the same co-signaling contribu- 
tion  as either  the FN-binding  receptor or CD8. 
ICAM-ls Enhances CTL Adhesion and Response to Atloan- 
tigen.  To determine the effect oflCAM-ls on the functional 
response of CTL to antigen, ICAM-ls, and antigenic H-2K  b 
were co-immobilized in microtiter wells. ICAM-ls was im- 
mobilized at 0.05/zg/well or 0.1 #g/well together with con- 
centrations  of K b alloantigen  ranging  from  0.0125  to 0.2 
#g/well. Adhesion and degranulation were determined in par- 
allel. Immobilized ICAM-ls did not stimulate serine esterase 
release from CTL in the absence of alloantigen,  but augmented 
alloantigen-induced  serine esterase  release from CTL when 
it was co-immobilized on the same surface at either 0.05 or 
0.1  /*g/well  (Fig.  4  A).  The  predominant  effect  of co- 
immobilized  ICAM-ls was to decrease the surface density 
of K b required to initiate a response, rather than to increase 
the maximal response level.  The presence of ICAM-ls also 
increased the level of CTL binding to the ICAM-ls/alloan- 
tigen coated surface,  as seen in Fig. 4 B. Increased binding 
was observed with 0.05 #g/well ICAM-ls, with no further 
increase seen in the presence of 0.1/zg/ml. These results sug- 
gest that the LFA-1/ICAM-1 interaction may increase adhe- 
sion between the surfaces to promote higher TCR and CD8 
occupancy at suboptimal class I density, but contribute no 
amplifying signal when TCP,, and CD8 occupancy is optimal. 
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Figure  4.  Co-immobilized ICAM-ls enhances CTL response to im- 
mobilized alloantigen. CTL clone 11 was cultured in wells coated with 
the indicated concentrations of K b alone or in wells coated with K b to- 
gether with 0.05 #g/well or 0.1/zg/well ICAM-ls. After a 5-h incuba- 
tion, percent specific serine esterase release (A) and percent specific binding 
(B)  were determined as described in Materials and Methods. --0-  K b 
alone; +  +.05  #g ICAM-ls; -~-  +.1  /zg ICAM-ls. 
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response  level even when class I density is optimal. 1 
CTL activation appears  to involve  a cascade of adhesion 
and signaling events with different accessory receptors making 
distinct contributions. The findings reported here indicate 
that while CTL binding to ICAM-1, class I MHC, and FN 
are all activated through the TCR, the relative contributions 
of these  interactions to  functional response  are  different. 
CD8/class I and VLA/FN interactions clearly provide costimu- 
latory signals leading respectively to initiation and amplification 
of PI hydrolysis (9). LFA-l-dependent adhesion can be acti- 
rated by antigen, but this appears to depend on both TCR 
and CD8 (Fig.  2),  suggesting a position downstream from 
these receptors in the activation cascade. Furthermore, if LFA-1 
provides a costimulatory signal,  as it can in some T cells (6, 
10), then the signal  clearly differs from those provided by 
binding to class I or FN (Fig. 3). At least in the case of CTL 
degranulation, one of the mechanisms for target lysis, the 
predominant contributions of LFA-1/ICAM-1 binding ap- 
pears to be to increase adhesion with the antigen bearing sur- 
face, thus  promoting  increased  occupancy  of  the  other 
receptors. 
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